Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool
Conclusions: In physician interactions with patients with opioid use disorder, there is a critical need to address comorbid physical health problems and account for patient medication preferences. Practice Implications: Findings reinforce the role physicians can play in communicating with patients about their comorbid conditions and about medication preferences. In the patient-physician interaction efforts to meet patients’ evolving treatment needs and preferences can be made by offering patients access to all available evidence-based treatments. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Original Research Source Type: research

Opioid-Related Disparities in Sexual Minority Youth, 2017
Conclusions: We demonstrated preliminary evidence sexual minority youth have significant opioid-related health disparities with greater odds of lifetime prescription opioid misuse and heroin use. As early exposure to opioids is associated with greater risk for developing an opioid use disorder and increased opioid-morbidity and mortality, it is critical that providers recognize and incorporate the unique needs for sexual minority youth into traditional treatment and prevention models. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Original Research Source Type: research

Daily Cannabis Use During Pregnancy and Postpartum in a State With Legalized Recreational Cannabis
Conclusions: In a state with legalized recreational cannabis, pregnant and postpartum women reported continuing daily cannabis use during pregnancy to take care of themselves and their baby. It is crucial for healthcare providers to follow national guidelines and explain risks of cannabis use during pregnancy and postpartum, while also managing expectations based on patient history. A harm reduction approach to decrease cannabis use is vital to help pregnant women who are using cannabis for health management to continuously evaluate their use during pregnancy and postpartum. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Original Research Source Type: research

Impact of Prenatal Exposure to Opioids, Cocaine, and Cannabis on Eye Disorders in Children
Conclusions: Prenatal substance exposure is significantly associated with future hospitalizations for eye disorders in childhood. Efforts to minimize substance use in women of reproductive age are needed in light of the current opioid epidemic. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Original Research Source Type: research

Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19
As a result of the coronavirus 2019 (Covid-19) pandemic, clinical research for substance use disorders (SUDs) has been impeded due to widespread stay-at-home mandates limiting the operations of “non-essential” work. Although appropriate to proceed with an abundance of caution to prevent viral spread, there will be detrimental consequences for patients with SUDs if clinical trials research cannot adapt and continue uninterrupted. The field of digital health has strong evidence for its feasibility and effectiveness and offers tools that can facilitate the continuation of SUD clinical trials research remotely in accordanc...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Review Source Type: research

Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies
The COVID-19 pandemic is likely to exacerbate existing anxiety and substance use disorders (SUDs) and increase vulnerability among individuals previously free of these conditions. Numerous pandemic-related stressors—coronavirus infection fears, social distancing and isolation, activity restrictions, financial insecurity and unemployment, caregiving or childcare responsibilities—place a substantial burden both on the general population and on many health care providers. Anxiety symptoms such as worry, tension, irritability, difficulty concentrating, and sleep disruption are increasingly prevalent. For individuals in SUD...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions
Correctional settings can be vectors of infectious diseases due to overcrowding, unsanitary living conditions, and very little capacity to engage in social distancing. In the US, COVID-19 outbreaks were first identified in the New York City and Cook County jails, with infection rates far exceeding community rates. Each day new cases are being identified across the country in correctional facilities. People who are incarcerated are at increased risk of experiencing severe COVID-19 symptoms because of the increased prevalence of other underlying illnesses. Jails and prisons have begun initiating facility-level policies to he...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs
Globally, there are concerns about access to healthcare and harm reduction services for people who use drugs (PWUD) during the coronavirus disease 2019 (COVID-19) pandemic. Members from the Network of Early Career Professionals working in Addiction Medicine shared their experiences of providing treatment to PWUD during the COVID-19 pandemic. Drawing on these qualitative reports, we highlight the similarities and discrepancies in access to services for PWUD in 16 countries under COVID-10 restrictions. In most countries reported here, efforts have been made to ensure continued access to services, such as mobilising opioid ag...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

The Changing Landscape of Alcohol Use and Alcohol Use Disorder During the COVID-19 Pandemic - Perspectives of Early Career Professionals in 16 Countries
Alcohol use is a major risk factor for infectious disease and reduction of harms associated with alcohol consumption are essential during times of humanitarian crises, such as the COVID-19 pandemic. As a network of early career professionals working in the area of addiction medicine, we provide our views with regards to national actions related to reducing alcohol-related harm and providing care for people with alcohol use disorder during COVID-19. We believe that COVID-19 related measures have affected alcohol consumption in the majority of countries represented in this commentary. Examples of these changes include change...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

Opioid Use Disorder in the Emergency Department Amid COVID-19
No abstract available (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

Greater Attention Paid to the Patient's Experience Could Improve the Treatment of Individuals With Opioid Use Disorder Hospitalized for Serious Infections
There is a growing recognition for the need to improve the treatment of individuals with opioid use disorder who are hospitalized for serious infections such as infective endocarditis. Unfortunately, patients face enormous hurdles not only in coping with the life-threatening medical illness, but also in maintaining their recovery and engagement with treatment due in part to the difficulties navigating the fragmented addiction treatment system. The journey mapping research presented by Bearnot and Mitton is a novel approach that has the potential to improve our understanding of the challenges faced by patients. Given the se...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

Addressing Missing Data in Substance Use Research: A Review and Data Justice-based Approach
Missing data in substance use disorder (SUD) research can pose a challenge as researchers attempt to publish reliable findings based on the limited available information. Tools to address missing data exist, but are underused and may not address all types of missingness. Missing data are more than a statistical problem: for underserved populations and people with SUDs who may have missing data for a myriad of reasons, missing data represents missing stories and information that can have real-world impacts on system and policy-level decision making. This paper reviews types of missing data and, through a data justice lens, ...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

The Potential Association Between Prenatal Cannabis Use and Congenital Anomalies
No abstract available (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

The Clinical Assessment of Vaping Exposure
Vaping, the inhalation of a nicotine or tetrahydrocannabinol (THC), cannabidiol (CBD), or non-drug infused solution delivered by vaping devices, is a growing phenomenon across many segments of the US population. Complications associated with vaping are newly emerging and relatively unstudied; little guidance exists on how clinicians may best elicit information related to vaping practices and associated medical problems. This publication, therefore, provides physicians and other treatment clinicians with direction for obtaining the medical history that can guide clinical decision-making for patients at risk for adverse effe...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research

Historical Perspective of Proactive and Reactive Regulations of E-cigarettes to Combat Nicotine Addiction
Abstract: Cigarettes and electronic cigarettes (e-cigarettes) are major sources of exposure to nicotine, an addictive chemical. Although these products are being regulated by the Food and Drug Administration (FDA) under the Tobacco Control Act, specifications about the nicotine content in these products have not been established yet. In e-cigarettes, nicotine concentration ranges from 0 to> 50mg/mL, and the recent e-cigarette devices provide control to change nicotine flux for higher nicotine delivery. Due to the lack of robust regulations in manufacturing, distribution and marketing, e-cigarettes have already infilt...
Source: Journal of Addiction Medicine - November 13, 2020 Category: Addiction Tags: Commentaries Source Type: research